Skip to content

Assessment of subconjunctival bevacizumab effect on the postoperative healing course and recurrence of excised pterygium

Assessment of subconjunctival bevacizumab effect on the postoperative healing course and recurrence of excised primary pterygium in patients referring to ophthalmology clinics

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138805192326N1
Enrollment
32
Registered
2010-09-28
Start date
2009-08-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pterygium. corneal degeneration

Interventions

Intervention 1: Intervention in cases: after excision of pterygium and rotational conjunctival flap,5 mg (0.2ml) of bevacizumab injected subconjunctivally in inferior fornix, and in the first post ope
Treatment - Drugs
Placebo
Intervention in cases: after excision of pterygium and rotational conjunctival flap,5 mg (0.2ml) of bevacizumab injected subconjunctivally in inferior fornix, and in the first post operative week addi
Intervention in controls: after excision of pterygium and rotational conjunctival flap, 0.2 ml of balanced salt solution, injected subconjunctivally in inferior fornix.

Sponsors

Vice-chancellery of Research Affairs of Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: the patients with primary pterygium referring to the ophthalmology clinics, affiliated to Shiraz University of Medical Sciences, that want pterygium removal. Exclusion criteria: glaucoma, regurgitation from lacrimal punctum (any indication of nasolacrimal obstruction), patients that seems not coming for follow-up exams during study, not treated diabetic patients, autoimmune diseases, pregnant patients, patients with ocular surface diseases or infections, two headed pterygium, previous limbal surgery, previous pterygial surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recurrence of pterygium. Timepoint: 1 month, 3 months, 6 months after operation. Method of measurement: Slit lamp examination and measuring the size of recurrent pterygial tissue on cornea.

Secondary

MeasureTime frame
Healing of the surgical wound. Timepoint: 1 week,1 month. Method of measurement: observing erythema, subconjunctival hemorrhage, corneal epithelial defect, tearing, photophobia of the patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Banifatemi

Shiraz university of medical sciences

mbanifatemi@gmail.com+98 71 1647 1479

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026